Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARCELLX, INC.

63.00
-0.8200-1.28%
Post-market: 63.000.00000.00%18:07 EDT
Volume:986.91K
Turnover:61.72M
Market Cap:3.47B
PE:-21.02
High:64.64
Open:64.25
Low:60.92
Close:63.82
Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (ACLX), Vir Biotechnology (VIR) and Liquidia Technologies (LQDA)

TIPRANKS
·
09 May

Arcellx Q1 EPS $(1.13) Misses $(0.77) Estimate, Sales $8.13M Miss $20.06M Estimate

Benzinga
·
09 May

Arcellx Inc: Ended Quarter With $565M in Cash, Which Is Expected to Fund Operations Into 2028

THOMSON REUTERS
·
09 May

Press Release: Arcellx Provides First Quarter 2025 Financial Results and Business Highlights

Dow Jones
·
09 May

Arcellx, Inc. (ACLX): Among Takeover Rumors Hedge Funds Are Buying

Insider Monkey
·
24 Apr

Arcellx (ACLX): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential

Insider Monkey
·
12 Apr

Analysts Are Bullish on These Healthcare Stocks: Illumina (ILMN), Arcellx Inc (ACLX)

TIPRANKS
·
01 Apr

BRIEF-Arcellx Appoints Andrew Galligan And Kristin Myers To Its Board Of Directors

Reuters
·
21 Mar

Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors

THOMSON REUTERS
·
21 Mar

We're Not Worried About Arcellx's (NASDAQ:ACLX) Cash Burn

Simply Wall St.
·
03 Mar

Evercore ISI Reaffirms Their Buy Rating on Arcellx Inc (ACLX)

TIPRANKS
·
03 Mar

Arcellx Inc (ACLX) Receives a Buy from Morgan Stanley

TIPRANKS
·
28 Feb

Bank of America Securities Keeps Their Buy Rating on Arcellx Inc (ACLX)

TIPRANKS
·
28 Feb

Truist Financial Keeps Their Buy Rating on Arcellx Inc (ACLX)

TIPRANKS
·
28 Feb

Barclays Sticks to Its Buy Rating for Arcellx Inc (ACLX)

TIPRANKS
·
28 Feb

Arcellx, Inc. (ACLX) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
28 Feb

Arcellx Inc - Ends Quarter With $626M, Cash Runway Into 2027

THOMSON REUTERS
·
28 Feb

Arcellx FY 2024 GAAP EPS $(2.00) Misses $(1.66) Estimate, Sales $107.936M Miss $121.765M Estimate

Benzinga
·
28 Feb

Arcellx Provides Fourth Quarter and Year-End 2024 Financial Results and Business Highlights

Business Wire
·
28 Feb

Is Arcellx, Inc. (ACLX) An Oversold Biotech Stock to Buy Now?

Insider Monkey
·
25 Feb